Skip to content

Microdosing research published in 2024

Page 2 of 3: studies 21 to 40 of 47, newest first. Back to the microdosing overview

Studies

Buprenorphine microdosing regimen using transdermal buprenorphine patches to transition from methadone to buprenorphine

Drug and Alcohol Review May 1, 2024 Thileepan Naren, Jon Cook, Paul MacCartney et al.

AbstractIntroductionThis case series records a cohort of patients treated with transdermal buprenorphine patches as part of a buprenorphine microdose induction protocol to transition from methadone to buprenorphine in a community setting. This has historically been a difficult process to manage in community settings and this case series explored a method to gradually manage this in an...

Microdosing Psychedelics: Current Evidence From Controlled Studies.

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging May 1, 2024 Robin J Murphy, Suresh Muthukumaraswamy, Harriet de Wit 31 citations

Taking regular low doses of psychedelic drugs (microdosing) is a practice that has drawn recent scientific and media attention for its potential psychotherapeutic effects. Yet, controlled studies evaluating this practice have lagged. Here, we review recent evidence focusing on studies that were conducted with rigorous experimental control. Studies conducted under laboratory settings using...

Expectancy Effects in Psychedelic Trials.

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging May 1, 2024 Balázs Szigeti, Boris D. Heifets 62 citations

Clinical trials of psychedelic compounds like psilocybin, lysergic acid diethylamide (LSD), and N,N-dimethyltrptamine (DMT) have forced a reconsideration of how nondrug factors, such as participant expectations, are measured and controlled in mental health research. As doses of these profoundly psychoactive substances increase, so does the difficulty in concealing the treatment condition in the...

DOI: 10.1016/j.bpsc.2024.02.004 (opens in new tab) Full text (opens in new tab) Microdosing Hallucinogen therapy Clinical-trials trial design Psychedelic-therapy psychedelic medicine +6

The Use of Microdosing for In vivo Phenotyping of Cytochrome P450 Enzymes: Where Do We Stand? A Narrative Review

European Journal of Drug Metabolism and Pharmacokinetics April 30, 2024 L. T. van der Heijden, F. Opdam, J. H. Beijnen et al.

Cytochrome P450 (CYP) enzymes play a central role in the elimination of approximately 80% of all clinically used drugs. Differences in CYP enzyme activity between individuals can contribute to interindividual variability in exposure and, therefore, treatment outcome. In vivo CYP enzyme activity could be determined with phenotyping. Currently, (sub)therapeutic doses are used for in vivo...

Inpatient Transition from Methadone to Buprenorphine–Naloxone Using a Microdosing Strategy in a Postoperative Cancer Patient: A Case Report

Journal of Palliative Medicine April 30, 2024 Min Ji Kim, H. Walker, Matthew D Clark et al.

Background: Buprenorphine initiation in opioid-tolerant patients usually requires decreasing the total opioid intake per day due to its potential for precipitating withdrawal. However, this strategy may not be tolerated in patients who require higher amounts of opioids, such as those with cancer pain. Case Presentation: We utilized a buprenorphine microdosing strategy for a postoperative cancer...

LSD increases sleep duration the night after microdosing.

Translational Psychiatry April 15, 2024 Nathan Allen, Aron Jeremiah, Robin J Murphy et al. 15 citations

Microdosing psychedelic drugs at a level below the threshold to induce hallucinations is an increasingly common lifestyle practice. However, the effects of microdosing on sleep have not been previously reported. Here, we report results from a Phase 1 randomized controlled trial in which 80 healthy adult male volunteers received a 6-week course of either LSD (10 µg) or placebo with doses...

Unlocking the self: Can microdosing psychedelics make one feel more authentic?

Nordisk alkohol- & narkotikatidskrift : NAT April 1, 2024 Ioana Pop, Jannis Dinkelacker 5 citations

Background and aim: In the present study, we focus on the relationship between state authenticity - the experience of being true to oneself in a particular moment - and microdosing - a practice that implies repeatedly ingesting very small doses of psychedelics that do not reach the threshold for perceptual alterations. We propose that microdosing could increase state authenticity through...

Microdosing psychedelics in the treatment of ADHD and comorbid disorders

European Psychiatry April 1, 2024 K. P. Kuypers 3 citations

Abstract Microdosing psychedelics has garnered considerable attention within both nonprofessional circles and the scientific community in recent years. This method involves taking small, non-hallucinogenic doses of substances like LSD or psilocybin over weeks or months, purportedly to enhance specific behaviors, emotions, or address psychiatric conditions. Exploring these assertions is crucial...

Greater subjective effects of a low dose of LSD in participants with depressed mood.

Neuropsychopharmacology April 1, 2024 Hanna Molla, Royce Lee, Ilaria Tare et al. 37 citations

Recent studies and anecdotal reports suggest that psychedelics can improve mood states, even at low doses. However, few placebo-controlled studies have examined the acute effects of low doses of LSD in individuals with psychiatric symptoms. In the current study, we examined the acute and sub-acute effect of a low dose of LSD (26 µg) on subjective effects and mood in volunteers with mild...

From Outsider to Insider: A Look at the Subculture of Microdosing

Deviant Behavior March 31, 2024 Blake Beaton, Jurg Gerber 2 citations

The practice of microdosing classic psychedelic drugs (e.g. LSD [lysergic acid diethylamide] and psilocybin) has not only become more commonplace, but has also been shown to have potential in treating various psychological impairments. Much is still unknown about how people who microdose psychedelic drugs learn the processes and protocols for microdosing. To uncover how people learn the various...

Microdosing of nitrogen fertiliser and cattle manure under in situ rainwater harvesting to improve maize production in smallholder farming system in a semiarid area of Zimbabwe

Journal of Sustainable Agriculture and Environment March 29, 2024 Andrew T. Kugedera, Letticia K. Kokerai

Abstract Introduction Maize production in smallholder farmers located in semiarid areas of Zimbabwe are mainly constrained by soil moisture and nutrient stress. Moisture stress is mainly due to erratic rainfall, high rates of evapotranspiration and limited knowledge of the use of in situ rainwater harvesting (IRWH) techniques. Tied ridges (TRs) are one of the best IRWH techniques which have...

DOI: 10.1002/sae2.12071 (opens in new tab) Full text (opens in new tab) Microdosing Nitrogen use efficiency Return on investment Semiarid areas

Dried Blood Spot Sampling of Testosterone Microdosing in Healthy Females.

Journal of Steroid Biochemistry and Molecular Biology March 1, 2024 R. Desai, S. Savkovic, D. Handelsman

Capillary dried blood spot (DBS) analysis coupled with multi-analyte steroid liquid chromatography mass spectrometry (LCMS) is attractive for field studies, home-based self-sampling as well as clinical trials by eliminating costly and laborious sample processing involving venipuncture and frozen storage/shipping while providing multiple steroid measurements from a single small sample. We...

Exploring the discourses around microdosing psychedelics within the r/microdosing online community

Social Science & Medicine February 22, 2024 Ioana Pop, Erwin Gielens, Hannah Kottmann et al. 4 citations

In the present contribution, we examine the practice of microdosing psychedelics (microdosing) through textual analysis of the content produced by a dedicated online community, the r/microdosing subreddit. We collected a comprehensive dataset of publicly available submissions from this community and used structural topic modelling to identify and analyse the prevalent topics within the...

DOI: 10.1016/j.socscimed.2024.116702 (opens in new tab) Sociocultural evolution Narrative Population Medicalization +8

Repeated microdoses of LSD do not alter anxiety or boldness in zebrafish.

Scientific Reports February 22, 2024 Ethan V Hagen, Melike Schalomon, Yanbo Zhang et al. 11 citations

The therapeutic use of lysergic acid diethylamide (LSD) has resurfaced in the last decade, prompting further scientific investigation into its effectiveness in many animal models. Zebrafish (Danio rerio) are a popular model organism in medical sciences and are used to examine the repeated administration of pharmacological compounds. Previous zebrafish research found acute LSD altered behaviour...

DOI: 10.1038/s41598-024-54676-8 (opens in new tab) Full text (opens in new tab) Microdosing Psychedelics Behavioral neuroscience Animal research +1

Impact of Microdosing Practices on Technical Efficiency: An Analysis Accounting for Selection Bias Among Smallholder Maize Farmers in Burkina Faso

Journal of Agricultural Science February 15, 2024 Didier Sawadogo, Ichizen Matsumura, Mohamed Esham et al.

Smallholder maize farmers are currently confronted with the arduous challenge of managing limited financial resources while incessantly facing the issue of land degradation. To address this issue, an alternative solution has been implemented to optimize the use of chemical fertilizer by adopting microdosing. This innovative system not only helps them enhance their agricultural productivity but...

PAM trial protocol: a randomised feasibility study of psychedelic microdosing-assisted meaning-centred psychotherapy in advanced stage cancer patients.

Pilot and Feasibility Studies February 12, 2024 Alesha Wells, A P Suresh Muthukumaraswamy, Eva Morunga et al. 10 citations

An advanced cancer diagnosis can be associated with a significant profile of distress. Psychedelic compounds have shown clinically significant effects in the treatment of psychological distress in patients with advanced-stage cancer. Given the challenges of delivering timely and effective intervention in the advanced cancer context, it is possible that an alternative, more pragmatic, approach...

Psychedelic Microdosing among Young Adults from Southern California

Journal of Psychoactive Drugs February 10, 2024 Alyssa F. Harlow, Peter S. Hendricks, Adam M. Leventhal et al. 6 citations

Despite common depictions in the media, there is little scientific evidence on microdosing psychedelic drugs. We assessed awareness, prevalence, and dosing practices of microdosing psychedelic drugs among young adults 18-22 years old from Southern California (2018-2019). We examined whether sociodemographic factors, personality traits, mental health, or other substance use behaviors were...

Microdosing ketamine in Drosophila does not block serotonin reuptake, but causes complex behavioral changes mediated by glutamate and serotonin receptors

Journal of Neurochemistry February 7, 2024 Kelly E. Dunham, Kani H. Khaled, Leah Weizman et al.

Microdosing ketamine is a novel antidepressant for treatment‐resistant depression. Traditional antidepressants, like selective serotonin reuptake inhibitors (SSRIs), inhibit serotonin reuptake, but it is not clear if ketamine shows a similar mechanism. Here, we tested the effects of feeding ketamine and SSRIs to Drosophila melanogaster larvae, which has a similar serotonin system to mammals and...

Keeping the promise: a critique of the current state of microdosing research

Frontiers in Psychiatry February 5, 2024 Rotem Petranker, Thomas Anderson, Youval Aberman et al. 14 citations

Introduction The practice of taking small, sub-hallucinogenic doses of psychedelics, known as microdosing, has exploded in popularity over the last decade. Users claim benefits ranging from improved mood and enhanced creativity to an increased sense of meaning and connectedness in life. While research on microdosing is still lagging behind the shift in public opinion, several papers have been...

Psychedelic Drug Microdosing Practices: A Qualitative Online Exploration

Journal of Psychoactive Drugs January 22, 2024 Estelle Miller, Vida Bojovic, Olivia Maddren et al.

ABSTRACT “Microdosing,” defined as the consumption of small, sub-hallucinogenic quantities of psychedelic drugs, has gained recent popularity. Microdosing is a relatively new concept, therefore no scientific recommendations exist on how to prepare and consume microdoses. Many consumers obtain microdosing information online. Few studies have investigated the content of this information; thus,...